SG-Logo.png
SOPHiA GENETICS to Present at the 40th Annual J.P. Morgan Healthcare Conference
29 déc. 2021 07h00 HE | SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, Dec. 29, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), announced today Chief Executive Officer and Co-Founder Dr. Jurgi Camblong and Chief Financial...
SG-Logo.png
SOPHiA GENETICS Reports Third Quarter 2021 Financial Results and Raises 2021 Guidance
10 nov. 2021 07h00 HE | SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, Nov. 10, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), today reported financial results for the third quarter ended September 30, 2021. Recent...
SG-Logo.png
SOPHiA GENETICS to Participate in Upcoming November Investor Conferences
28 oct. 2021 16h05 HE | SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, Oct. 28, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced the company will be participating virtually in the following investor...
SG-Logo.png
SOPHiA GENETICS to Report Third Quarter 2021 Financial Results on November 10, 2021
27 oct. 2021 16h05 HE | SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, Oct. 27, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the third quarter of 2021 before market...
SG-Logo.png
SOPHiA GENETICS Reports Second Quarter 2021 Financial Results and Issues 2021 Guidance
09 sept. 2021 07h00 HE | SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, Sept. 09, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (NASDAQ: SOPH), today reported financial results for the three months ended June 30, 2021. Recent...
SG-Logo.png
SOPHiA GENETICS to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
30 août 2021 16h05 HE | SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, Aug. 30, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), today announced the company will be participating in the Morgan Stanley 19th Annual Global...
SG-Logo.png
UPDATE – SOPHiA GENETICS to Report Second Quarter 2021 Financial Results on September 9, 2021
26 août 2021 12h43 HE | SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, Aug. 26, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the second quarter of 2021 before market...
SG-Logo.png
SOPHiA GENETICS to Report Second Quarter 2021 Financial Results on September 9, 2021
26 août 2021 09h00 HE | SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, Aug. 26, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the second quarter of 2021 before market...
SG-Logo.png
SOPHiA GENETICS Announces Closing of $234 Million Initial Public Offering and $20 Million Private Placement
27 juil. 2021 16h05 HE | SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, July 27, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven...
SG-Logo.png
SOPHiA GENETICS Announces Pricing of Initial Public Offering
22 juil. 2021 18h05 HE | SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, July 22, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA, the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine,...